51岁女性间质性肺疾病合并COVID-19后呼吸困难加重
一例51岁波多黎各女性,2002年起疑诊间质性肺疾病(ILD),影像呈「铺路石征」,支气管肺泡灌洗及活检见泡沫状巨噬细胞,肺功能示孤立性弥散功能缺陷。2020年8月患中度COVID-19,9月因呼吸困难复发再入院,本次为9月出院后4个月因劳力性呼吸困难亚急性加重就诊。
要点
- ILD患者感染COVID-19后呼吸困难加重需鉴别ILD进展与感染后遗症。
- 「铺路石征」伴泡沫状巨噬细胞提示需排查外源性脂质性肺炎等特定病因。
- 孤立性弥散功能缺陷可在多年内保持稳定,但COVID-19可能打破平衡。
核心结论
- 该病例展示一例诊断未明的ILD患者在COVID-19后出现亚急性劳力性呼吸困难加重,需综合评估ILD进展与感染后遗效应。
研究设计与样本
- 单例病例报告:51岁波多黎各女性,2002年起疑诊ILD,2020年8月中度COVID-19住院,2020年9月因呼吸困难复发再住院,本次为2020年9月出院后4个月就诊。
主要发现
- 胸部CT示「铺路石征」,即磨玻璃影叠加小叶间隔增厚及可见小叶内线。
- 支气管镜检查气道正常,BAL液清亮、见泡沫状巨噬细胞、培养阴性。
- VATS及经支气管活检均示泡沫状巨噬细胞。
- 肺功能示孤立性DLCO弥散功能缺陷。
- 多年来仅轻度非进展性功能受损,运动耐量稳定。
临床怎么用
- 对ILD合并COVID-19后呼吸困难加重的患者,应复查影像与肺功能以区分ILD进展与感染后改变。
- 影像呈「铺路石征」伴泡沫状巨噬细胞时,应考虑外源性脂质性肺炎等可治病因。
局限性
- 单例病例报告,结论不能外推至其他ILD患者。
- 原文未报告具体肺功能数值、影像定量及随访结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 51-year-old Puerto Rican woman, with a known but inconclusive diagnosis of interstitial lung disease (ILD) since 2002 and recent moderate COVID-19, is now presenting with subacute worsening dyspnea on exertion. The patient had sporadic medical care over the years for her ILD (Table 1). Prior workup included chest CT imaging with a "crazy-paving" pattern of lung disease, as defined by ground-glass opacity with superimposed interlobular septal thickening and visible intralobular lines. Bronchoscopy showed normal airway examination, and BAL revealed clear fluid with foamy macrophages and negative cultures. Video-assisted thoracoscopic surgery and transbronchial biopsy specimens both showed foamy macrophages. Results of pulmonary function testing (PFT) revealed an isolated gas transfer defect on diffusing capacity of the lungs for carbon monoxide (Dlco). She had lived with mild yet nonprogressive functional impairment and stable exercise intolerance over these years. She was then hospitalized for COVID-19 in August 2020 and for recurrent shortness of breath in September 2020. She now presented 4 months following her September 2020 hospitalization.
引用
- Ng N, Zatakia J, Beasley MB, et al. A 51-Year-Old Woman With Interstitial Lung Disease and Subsequent COVID-19 Presenting With Worsening Dyspnea. Chest. 2022. PMID: 35809945. doi:10.1016/j.chest.2022.01.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。